Dexamethasone Intravitreal Implant (Ozurdex) for Long-Term Macular Edema after Epiretinal Membrane Peeling Surgery

Table 1

Patient demographics at baseline.

Feature	IVD group	Control group	p value
Patient number	20	20	1
Age (years)	63.9 ± 6.2	62.8 ± 5.8	0.57
Male : female	10 : 10	8 : 12	0.75
Interval from PPV to IVD or baseline (wks)	58.8 ± 4.0	57.7 ± 4.0	0.61
LogMAR BCVA	0.81 ± 0.30	0.75 ± 0.38	0.58
CFT (μm)	450.7 ± 72.4	466.2 ± 82.8	0.53

BCVA: best-corrected visual acuity; CFT: central foveal thickness; IVD: dexamethasone intravitreal injection; logMAR: logarithm of the minimum angle of resolution.